Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 3

Pharmacogenomics and Personalized Medicine


Archive: Volume 3, 2010

Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management

Sarah Rofaiel, Esther N Muo, Shaker A Mousa

Pharmacogenomics and Personalized Medicine 2010, 3:129-143

Published Date: 17 September 2010

The future role of personalized medicine in the treatment of glioblastoma multiforme

Jing Li, Chunhui Di, Austin K Mattox, et al

Pharmacogenomics and Personalized Medicine 2010, 3:111-127

Published Date: 19 August 2010

Antiplatelet agents and proton pump inhibitors – personalizing treatment

Eugene Lin, Rajiv Padmanabhan, Majaz Moonis

Pharmacogenomics and Personalized Medicine 2010, 3:101-109

Published Date: 28 June 2010

Impact of genetic polymorphisms on clinical response to antithrombotics

Kena J Lanham, Julie H Oestreich, Steven P Dunn, et al

Pharmacogenomics and Personalized Medicine 2010, 3:87-99

Published Date: 18 June 2010

Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab

Naveed Wagle, Leia Nghiemphu, Albert Lai, et al

Pharmacogenomics and Personalized Medicine 2010, 3:79-85

Published Date: 9 June 2010

DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics

Darko Turic, James Swanson, Edmund Sonuga-Barke

Pharmacogenomics and Personalized Medicine 2010, 3:61-78

Published Date: 21 May 2010

Determinants to optimize response to clopidogrel in acute coronary syndrome

Betti Giusti, Anna Maria Gori, Rossella Marcucci, et al

Pharmacogenomics and Personalized Medicine 2010, 3:33-50

Published Date: 8 April 2010